Skip to content Skip to navigation

Heroin vaccine shows promise in animal model

July 21, 2011
by News release
| Reprints

NIDA-funded researchers have developed a vaccine that blocks heroin-mediated reward and pain relief in rats. The vaccine works by generating antibodies against the drug itself. These antibodies bind heroin while still in the bloodstream, reduce its entry into the brain, thereby blocking its effects on pain and reward.
Although more research is needed, this finding offers promise for the development of a heroin vaccine for humans, which would be an important step in the battle against heroin addiction, and associated illnesses such as HIV.

Click here for a copy of the article. For more information, contact the NIDA Press Office at (301) 443-6245 or media@nida.nih.gov.

Topics